Brian A Mendelsohn

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Topics

Gas Chromatography

Diffusion Weighted

Structure Activity Relationship

Top Venues

Organic letters

Molecular pharmaceutics

Bioconjugate chemistry

Analytical chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Yutaka Matsuda, Natsuki Shikida, Noriko Hatada, Kei Yamada, Takuya Seki, Yuichi Nakahara, Yuta Endo, Kazutaka Shimbo, Kazutoshi Takahashi, Akira Nakayama, Brian A Mendelsohn, Tomohiro Fujii, Tatsuya Okuzumi, Shigeo Hirasawa
AJICAP-M: Traceless Affinity Peptide Mediated Conjugation Technology for Site-Selective Antibody-Drug Conjugate Synthesis. Organic letters (2024)
Yutaka Matsuda, Natsuki Shikida, Noriko Hatada, Kei Yamada, Takuya Seki, Yuichi Nakahara, Yuta Endo, Kazutaka Shimbo, Kazutoshi Takahashi, Akira Nakayama, Brian A Mendelsohn, Tomohiro Fujii, Tatsuya Okuzumi, Shigeo Hirasawa
AJICAP-M: Traceless Affinity Peptide Mediated Conjugation Technology for Site-Selective Antibody-Drug Conjugate Synthesis. Organic letters 26 (27) (2024)
Yutaka Matsuda, Natsuki Shikida, Noriko Hatada, Kei Yamada, Takuya Seki, Yuichi Nakahara, Yuta Endo, Kazutaka Shimbo, Kazutoshi Takahashi, Akira Nakayama, Brian A Mendelsohn, Tomohiro Fujii, Tatsuya Okuzumi, Shigeo Hirasawa
AJICAP-M: Traceless Affinity Peptide Mediated Conjugation Technology for Site-Selective Antibody-Drug Conjugate Synthesis. Organic letters 26 (27) (2024)
Tomohiro Fujii, Yutaka Matsuda, Takuya Seki, Natsuki Shikida, Yusuke Iwai, Yuri Ooba, Kazutoshi Takahashi, Muneki Isokawa, Sayaka Kawaguchi, Noriko Hatada, Tomohiro Watanabe, Rika Takasugi, Akira Nakayama, Kazutaka Shimbo, Brian A Mendelsohn, Tatsuya Okuzumi, Kei Yamada
AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody-Drug Conjugate Production. Bioconjugate chemistry (2023)
Yutaka Matsuda, Takuya Seki, Kei Yamada, Yuri Ooba, Kazutoshi Takahashi, Tomohiro Fujii, Sayaka Kawaguchi, Takahiro Narita, Akira Nakayama, Yoshiro Kitahara, Brian A Mendelsohn, Tatsuya Okuzumi
Chemical Site-Specific Conjugation Platform to Improve the Pharmacokinetics and Therapeutic Index of Antibody-Drug Conjugates. Molecular pharmaceutics 18 (11) (2021)
Tomohiro Fujii, Calliste Reiling, Colette Quinn, Michal Kliman, Brian A Mendelsohn, Yutaka Matsuda
Physical characteristics comparison between maytansinoid-based and auristatin-based antibody-drug conjugates. Exploration of targeted anti-tumor therapy 2 (6) (2021)
Yutaka Matsuda, Brian A Mendelsohn
An overview of process development for antibody-drug conjugates produced by chemical conjugation technology. Expert opinion on biological therapy 21 (7) (2020)
Yutaka Matsuda, Michal Kliman, Brian A Mendelsohn
Application of Native Ion Exchange Mass Spectrometry to Intact and Subunit Analysis of Site-Specific Antibody-Drug Conjugates Produced by AJICAP First Generation Technology. Journal of the American Society for Mass Spectrometry (2020)
Yutaka Matsuda, Veronica Robles, Maria-Christina Malinao, James Song, Brian A Mendelsohn
Comparison of Analytical Methods for Antibody-Drug Conjugates Produced by Chemical Site-Specific Conjugation: First-Generation AJICAP. Analytical chemistry 91 (20) (2019)
Josh T Snyder, Maria-Christina Malinao, Julien Dugal-Tessier, John E Atkinson, Banmeet S Anand, Akihiro Okada, Brian A Mendelsohn
Metabolism of an Oxime-Linked Antibody Drug Conjugate, AGS62P1, and Characterization of Its Identified Metabolite. Molecular pharmaceutics 15 (6) (2018)
Brian A Mendelsohn, Stuart D Barnscher, Josh T Snyder, Zili An, Jennifer M Dodd, Julien Dugal-Tessier
Investigation of Hydrophilic Auristatin Derivatives for Use in Antibody Drug Conjugates. Bioconjugate chemistry 28 (2) (2017)
Julien Dugal-Tessier, Stuart D Barnscher, Akira Kanai, Brian A Mendelsohn
Synthesis and Evaluation of Dolastatin 10 Analogues Containing Heteroatoms on the Amino Acid Side Chains. Journal of natural products 80 (9) (2017)